A phase 1 study of ADX-629
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2019
Price : $35 *
At a glance
- Drugs ADX-629 (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
- 08 Mar 2019 According to an Aldeyra Therapeutics media release, this trial is expected to begin in the second half of 2019.
- 04 Jul 2018 New trial record
- 26 Jun 2018 According to an Aldeyra Therapeutics media release, this study is expected to start in 2019.